促进酒精使用障碍的药物开发:综合临床前,人体实验室和临床试验的叙述性综述
Steven J Nieto1, Lara A Ray2,3
1Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
Alcohol, clinical & experimental research
|October 14, 2025
概括
开发用于治疗酒精使用障碍 (AUD) 的新药是复杂的. 本综述强调了临床前和人体实验室研究如何预测临床试验的成功,改善AUD药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床试验 临床试验
背景情况:
- 对酒精使用障碍 (AUD) 的药物开发是一个漫长而昂贵的过程.
- 目前的发展涉及动物模型,人体实验室研究和随机临床试验 (RCT).
研究的目的:
- 评估在临床前,人体实验室和临床试验阶段AUD药物开发的最佳实践.
- 评估早期疗效数据对临床结果的预测价值.
- 在AUD药物开发中为数据驱动的决策提供信息.
主要方法:
- 对AUD药物开发的数据驱动研究的审查.
- 在早期疗效测试中对行为药理学范式的评估.
- 应用一个翻译元分析方法,整合跨开发阶段的数据.
主要成果:
- 临床前和人体实验室证据对于去/不去的决定至关重要.
- 样本特征和研究设计影响药物效应的检测.
- 早期的疗效信号可以预测特定的临床试验结果.
结论:
- 为了可靠的AUD药物开发,需要标准化的方法.
- 在各个开发阶段整合数据可以提高决策能力.
- 桥梁临床前和临床研究促进有效的AUD药物开发.
相关概念视频
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
CNS Depressants: Alcohol and Nicotine
1.0K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.0K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K


